Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,769–2,776 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
MetaVia Inc. Gemcabene - COBALT-1 Homozygous Familial Hypercholesterolemia (HoFH) Phase 2b Trial Discontinued Oral Cardiology
MetaVia Inc. Gemcabene Dyslipidemia Phase 2 Trial Discontinued Oral Cardiology
MetaVia Inc. Vanoglipel (DA-1241) Metabolic dysfunction-associated steatohepatitis (MASH) Phase 2a Data Released Oral Gastroenterology
Milestone Pharmaceuticals Inc. Etripamil - (NODE-303) Paroxysmal supraventricular tachycardia (PSVT) Phase 3 Data Released Intranasal Cardiology
Milestone Pharmaceuticals Inc. Etripamil - (NODE-301) Paroxysmal supraventricular tachycardia (PSVT) Phase 3 Data Released Intranasal Cardiology
Milestone Pharmaceuticals Inc. Etripamil - NODE-302 Paroxysmal supraventricular tachycardia (PSVT) Phase 3 Trial Completed Intranasal Cardiology
Milestone Pharmaceuticals Inc. Etripamil (ReVeRA) Atrial fibrillation Phase 2/3 Trial Planned Intranasal Cardiology
MiMedx Group Inc mdHACM - (KOA) Knee Osteoarthritis Phase 2b Trial Discontinued Intra-articular Orthopedic